CD40L Antagonism in Rheumatoid Arthritis (RA) (CONTROL-RA)
Combining a CD40L-Binding Protein (VIB4920) With a TNF-alpha Inhibitor for the Treatment of Inadequately Controlled Rheumatoid Arthritis (ITN092AI)
Sponsor: Immune Tolerance Network (ITN)
Terminated
The study is being closed early due to insufficient participant enrollment across study sites.
Other terminated trials from Immune Tolerance Network (ITN)
Other Rheumatoid Arthritis trials with similar outcome
A PHASE2 clinical study on Rheumatoid Arthritis, this trial is terminated or withdrawn. The trial is conducted by Immune Tolerance Network (ITN) and has accumulated 23 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
23 versions recorded-
Feb 2026 — Present [monthly]
Terminated PHASE2
Status: Withdrawn → Terminated
-
Sep 2025 — Feb 2026 [monthly]
Withdrawn PHASE2
Status: Recruiting → Withdrawn
-
Aug 2025 — Sep 2025 [monthly]
Recruiting PHASE2
-
May 2025 — Aug 2025 [monthly]
Recruiting PHASE2
-
Apr 2025 — May 2025 [monthly]
Recruiting PHASE2
Status: Active Not Recruiting → Recruiting
▶ Show 18 earlier versions
-
Oct 2024 — Apr 2025 [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
Status: Not Yet Recruiting → Active Not Recruiting
-
Dec 2023 — Mar 2024 [monthly]
Not Yet Recruiting PHASE2
-
Nov 2023 — Dec 2023 [monthly]
Not Yet Recruiting PHASE2
Status: Recruiting → Not Yet Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Recruiting PHASE2
-
Aug 2023 — Oct 2023 [monthly]
Recruiting PHASE2
-
Jul 2023 — Aug 2023 [monthly]
Recruiting PHASE2
-
May 2023 — Jul 2023 [monthly]
Recruiting PHASE2
-
Apr 2023 — May 2023 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2023 — Apr 2023 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2023 — Mar 2023 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2022 — Feb 2023 [monthly]
Not Yet Recruiting PHASE2
-
Nov 2022 — Dec 2022 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE2
-
May 2022 — Jul 2022 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Immune Tolerance Network (ITN)
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .